Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults

Program Overview

Explore the world of hereditary angioedema (HAE)—its underlying pathophysiology, the real-world burden it places on patients, and its profound impact on quality-of-life. This activity will guide you through the latest diagnostic criteria and treatment guidelines, spotlighting both long-term prophylactic strategies and on-demand therapies. Discover how to assess quality-of-life with validated tools, analyze compelling case studies, and stay ahead with data on emerging therapies.

Credit Expired

Target Audience

Allergy/clinical immunology, primary care, and pediatric clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Explain the burden of hereditary angioedema (HAE)
  • Incorporate objective HAE quality-of-life assessment into clinical practice
  • Evaluate how emerging HAE on-demand and prophylactic therapies may improve patient outcomes
  • Create personalized HAE treatment plans

Activity Faculty

DrRiedl 1000x1000

Marc A. Riedl, MD, MS

Professor, Medicine
HAE Community Endowed Chair
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief and Training Program Director
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources